Increased Risk for Group B Streptococcus Sepsis in Young Infants Exposed to HIV, Soweto, South Africa, 2004–20081 - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 4—April 2015
Increased Risk for Group B Streptococcus Sepsis in Young Infants Exposed to HIV, Soweto, South Africa, 2004–20081
In 2013, a total of 41.6% (2.6 million) of deaths worldwide in children <5 years of age occurred in neonates; 76.7% occurred within 6 days after birth (1). Furthermore, in 2012, ≈6.9 million probable cases of severe bacterial infections and 680,000 associated deaths occurred among neonates (2). Nevertheless, there is a paucity of data from low- and middle-income countries on pathogen-specific causes of neonatal sepsis, particularly during the first day of life, and it is unknown whether in utero HIV exposure increases susceptibility to severe neonatal bacterial infections.
Group B Streptococcus (GBS) is a leading cause of severe invasive disease in young infants. A meta-analysis dominated by studies from high-income countries estimated global incidence of 0.53 cases/1,000 live births during 2000–2011 (3). Considerable intra- and interregional variation in the incidence of invasive early-onset disease (EOD; disease in 0- to 6-day-old infants ) was observed (3–5), ranging from 1.21 cases/1,000 live births (95% CI 0.5–1.91) in Africa to 0.02 cases/1,000 live births (95% CI 0–0.07) in Southeast Asia (3). This variability is inconsistent with the lesser difference in prevalence of maternal GBS colonization, the major risk factor for EOD, in women from different regions (20.9% in Africa, 13.4% in Southeast Asia) (6). Maternal HIV infection has not been associated with a higher prevalence of GBS colonization (7,8), except among women with CD4+ lymphocyte counts of >500 cells/mm3 (8).
Providing intrapartum antimicrobial drug prophylaxis (IAP) to women identified as rectovaginally colonized by GBS at 35–37 weeks’ of pregnancy has been associated with a >80.0% reduction in EOD (9); however, this strategy is logistically challenging to implement and maintain in resource-constrained settings. Furthermore, IAP has not decreased the incidence of late-onset disease (LOD; disease in 7- to 90-day-old infants) (10).
Progress has been made in the development of a trivalent GBS polysaccharide–protein conjugate vaccine (GBS-CV), which is targeted for use in pregnant women; the goal is to enhance transplacental transfer of capsular antibody to the fetus (1,8–10), which could protect against EOD and LOD. Improved estimates of the incidence of invasive GBS disease are needed from low- and middle-income countries to contextualize the prioritization of GBS vaccination and determine whether temporal changes in invasive serotypes should be considered in the design of serotype-specific GBS vaccine.
We evaluated the clinical and microbiological epidemiology, incidence, and serotype distribution of invasive GBS disease among young infants in a setting with a high prevalence of maternal HIV infection. A secondary aim was to estimate the potential effect of a trivalent GBS-CV in reducing the number of invasive GBS cases nationally.
Dr. Cutland is a senior research medical doctor in the Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, and PhD student at the University of the Witwatersrand. Her research interests include epidemiology and prevention of vaccine-preventable diseases in children, particularly young infants.
We thank the staff of Departments of Obstetrics, Neonatology, and Paediatrics at CHBAH for their dedication to their patients, including our study participants. We also thank Mannikhant Khoosal for assisting with sample collection and logistical support; Suzett Fourie, Veebha Gosai, Razia Hassan Moosa, Waasila Jassat, Stephanie Jones, Anthonet Koen, Marianne Kohler, Martin Laque and Albert Maribe for collection and analysis of data; and Mashudu Madzivhandila for sample processing.
This study was supported by the United States Agency for International Development, the National Vaccine Program Office, and the Antimicrobial Resistance Working Group of the Centers for Disease Control and Prevention (cooperative agreement nos. U50/CCU021960 and 5U01CI000318), and the Bill and Melinda Gates Foundation (grant no. 39415). Additional funding was provided by the Respiratory and Meningeal Pathogens Research Unit of the South African Medical Research Council.
The CHBAH Respiratory and Meningeal Pathogens Research Unit receives institutional grant support related to GBS from Novartis. S.A.M., C.L.C., and M.J.G. are clinical investigators in the Novartis GBS conjugate vaccine program.
- Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:957–79.PubMed
- Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA, Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, South Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:731–41. DOIPubMed
- Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379:547–56. DOIPubMed
- Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012;55:91–102 and. DOIPubMed
- Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J.2009;28(Suppl):S10–8. DOIPubMed
- Kwatra GC, Cunnington M, Valencia C, Adrian PV, Ip M, Klugman K, Maternal colonization with group B Streptococcus: do rates vary across regions? In: Abstracts of the 8th World Congress of World Society for Pediatric Infectious Diseases; Cape Town, South Africa. 2013 Nov 19–22. Abstract P-291. Geneva: Kenes International; 2013.
- Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet. 2009;374:1909–16. DOIPubMed
- Gray KJ, Kafulafula G, Matemba M, Kamdolozi M, Membe G, French N, Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008–2010. Emerg Infect Dis. 2011;17:1932–5. DOIPubMed
- Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA. 2008;299:2056–65. DOIPubMed
- Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev.2014;6:CD007467 .PubMed
- Statistics South Africa. Mid-year population estimates, 2013 [cited 2014 Jul 28]. http://beta2.statssa.gov.za/?page_id=1854&PPN=P0302&SCH=5500
- Republic of South Africa. National Health Act, 2004. Government Gazette. 2003;469, no. 61 [cited 2014 Jul 18].http://www.health.gov.za/docs/acts/2004/a61-03.pdf
- National Coordinating Committee for the Millennium Development Goals. Millenium development goals, country report 2013 [cited 2014 Jul 29].http://beta2.statssa.gov.za/MDG/MDGR_2013.pdf
- Department of Health. South Africa. Progress report on declaration of commitment on HIV and AIDS, Republic of South Africa. 2008 [cited 2014 Jul 18]. http://www.gov.za/sites/www.gov.za/files/prog-rpt_hiv-aids_0607.pdf
- Madzivhandila M, Adrian PV, Cutland CL, Kuwanda L, Schrag SJ, Madhi SA. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal–newborn dyads. PLoS ONE. 2011;6:e17861. DOIPubMed
- Schrag SJ, Cutland CL, Zell ER, Kuwanda L, Buchmann EJ, Velaphi SC, Risk factors for neonatal sepsis and perinatal death among infants enrolled in the Prevention of Perinatal Sepsis Trial, Soweto, South Africa. Pediatr Infect Dis J. 2012;31:821–6. DOIPubMed
- Statistics South Africa. Recorded live births, 2012 [cited 2014 Jul 29]. http://beta2.statssa.gov.za/?page_id=1854&PPN=P0305&SCH=5604
- Department of Health. Republic of South Africa. The 2011 National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa [cited 2014 Jul 29]. http://www.health-e.org.za/wp-content/uploads/2013/05/f0980fb5107a7ce543a8bd5730e52333.pdf
- Heyderman R, French N, Madhi SA, Cutland CL, Ngwira B, Mboizi R, Safety and immunogenicity of investigational group B Streptococcus trivalent polysaccharide-conjugate vaccine in HIV-infected and uninfected pregnant African women and newborns [cited 2015 Feb 11]. In: Abstracts of the 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases; May 6–10, 2014; Dublin Ireland; 2014. Abstract ESPID-1120.http://espid2015.kenes.com/PublishingImages/scientific-information/espid-abstracts/ESPID%202014%20abstracts.pdf
- Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11:497–513.PubMed
- Madhi SA, Radebe K, Crewe-Brown H, Frasch CE, Arakere G, Mokhachane M, High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr. 2003;23:15–23. DOIPubMed
- Haffejee IE, Bhana RH, Coovadia YM, Hoosen AA, Marajh AV, Gouws E. Neonatal group B streptococcal infections in Indian (Asian) babies in South Africa. J Infect. 1991;22:225–31. DOIPubMed
- Darmstadt GL, Saha SK, Choi Y, El Arifeen S, Ahmed NU, Bari S, Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis. 2009;200:906–15. DOIPubMed
- Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics. 2010;126:e631–8. DOIPubMed
- Cutland CL, Schrag SJ, Zell ER, Kuwanda L, Buchmann E, Velaphi SC, Maternal HIV infection and vertical transmission of pathogenic bacteria.Pediatrics. 2012;130:e581–90. DOIPubMed
- Taha TE, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi. Int J Epidemiol. 1995;24:1022–9. DOIPubMed
- Barron P, Pillay Y, Doherty T, Sherman G, Jackson D, Bhardwaj S, Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013;91:70–4. DOIPubMed
- Dangor Z, Kwatra G, Izu A, Lala SG, Madhi SA. Review on the association of group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines. 2015;14:135–49. DOIPubMed
- Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305:576–84. DOIPubMed
- Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014;28:531–41. DOIPubMed
- Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176:11–22. DOIPubMed
- Muenchhoff M, Prendergast AJ, Goulder PJ. Immunity to HIV in early life. Frontiers in Immunology. 2014;5:391.
- van den Berg JP, Westerbeek EA, van der Klis FR, Berbers GA, van Elburg RM. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev. 2011;87:67–72. DOIPubMed
- Feikin DR, Scott JA, Gessner BD. Use of vaccines as probes to define disease burden. Lancet. 2014;383:1762–70. DOIPubMed
- Tolockiene E, Morsing E, Holst E, Herbst A, Ljungh A, Svenningsen N, Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand. 2001;80:511–8. DOIPubMed
Suggested citation for this article: Cutland CL, Schrag SJ, Thigpen MC, Velaphi SC, Wadula J, Adrian PV, et al. Increased risk for group B Streptococcussepsis in young infants exposed to HIV, Soweto, South Africa, 2004–2008. Emerg Infect Dis. 2015 Apr [date cited].http://dx.doi.org/10.3201/eid2104.141562
1Preliminary results from this study were presented at the 8th World Congress of the World Society for Pediatric Infectious Diseases, November 19–22, 2013, Cape Town, South Africa.
No hay comentarios:
Publicar un comentario